MF Press

1.1k total citations
30 papers, 279 citations indexed

About

MF Press is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, MF Press has authored 30 papers receiving a total of 279 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 14 papers in Pulmonary and Respiratory Medicine and 11 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in MF Press's work include HER2/EGFR in Cancer Research (19 papers), Advanced Breast Cancer Therapies (11 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). MF Press is often cited by papers focused on HER2/EGFR in Cancer Research (19 papers), Advanced Breast Cancer Therapies (11 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). MF Press collaborates with scholars based in United States, United Kingdom and Spain. MF Press's co-authors include M S Mitchell, Roberta McKean‐Cowdin, Laurence N. Kolonel, MC Pike, Brian E. Henderson, Michael Arbushites, Gϋnter von Minckwitz, SA Hurvitz, Tanja Fehm and Jean Marie Bruey and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Annals of Oncology.

In The Last Decade

MF Press

29 papers receiving 274 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
MF Press United States 9 233 117 92 74 54 30 279
Richard Finn United States 3 245 1.1× 137 1.2× 109 1.2× 47 0.6× 24 0.4× 4 301
Karen Yuan United States 6 153 0.7× 80 0.7× 160 1.7× 33 0.4× 30 0.6× 18 270
Rochelle Strenger United States 6 370 1.6× 131 1.1× 46 0.5× 164 2.2× 60 1.1× 19 414
Danai Fimereli Belgium 7 211 0.9× 81 0.7× 63 0.7× 140 1.9× 67 1.2× 10 294
JMS Bartlett United Kingdom 7 188 0.8× 54 0.5× 186 2.0× 39 0.5× 48 0.9× 8 337
Federica Predolini United States 9 148 0.6× 47 0.4× 81 0.9× 35 0.5× 50 0.9× 12 275
Małgorzata Foszczyńska‐Kłoda Poland 5 220 0.9× 44 0.4× 141 1.5× 73 1.0× 78 1.4× 8 311
Luca Boscolo Bielo Italy 10 132 0.6× 40 0.3× 58 0.6× 79 1.1× 63 1.2× 27 211
Elisa Minenza Italy 9 182 0.8× 32 0.3× 59 0.6× 31 0.4× 117 2.2× 12 245
Daniela Boggiani Italy 9 195 0.8× 29 0.2× 81 0.9× 80 1.1× 123 2.3× 15 279

Countries citing papers authored by MF Press

Since Specialization
Citations

This map shows the geographic impact of MF Press's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by MF Press with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites MF Press more than expected).

Fields of papers citing papers by MF Press

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by MF Press. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by MF Press. The network helps show where MF Press may publish in the future.

Co-authorship network of co-authors of MF Press

This figure shows the co-authorship network connecting the top 25 collaborators of MF Press. A scholar is included among the top collaborators of MF Press based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with MF Press. MF Press is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wong, Wendy, Debra Lynch Kelly, Rosemary Makar, et al.. (2017). Abstract P1-03-03: High concordance of ER, PR, HER2 and Ki67 by central IHC and FISH with mRNA measurements by GeneXpert® breast cancer stratifier assay. Cancer Research. 77(4_Supplement). P1–3. 1 indexed citations
2.
Damaraju, Sambasivarao, Karen A. Gelmon, José Á. García-Sáenz, et al.. (2016). Abstract P1-13-03: Genome wide association study (GWAS) of genetic variants associated with docetaxel toxicity in the ROSE/TRIO-012 trial. Cancer Research. 76(4_Supplement). P1–13. 1 indexed citations
3.
Jiang, Yuqiu, Sophia Randolph, Patricia A. English, et al.. (2014). Cell Cycle Biomarker Analysis from the Paloma-1/ Trio 18 Palbociclib Plus Letrozole Phase Ii Study in Er-Positive/Her2-Negative Advanced Breast Cancer (Abc). Annals of Oncology. 25. iv146–iv146. 6 indexed citations
4.
Lu, Yunfeng, et al.. (2012). Abstract P4-08-05: Basement membrane localized tumor cells are protected from HER2-targeted therapy in vivo.. Cancer Research. 72(24_Supplement). P4–8. 1 indexed citations
5.
Christiansen, Jason, Nashwa Barakat, Derek Murphy, et al.. (2012). Abstract PD02-01: Her2 expression measured by AQUA analysis on BCIRG-005 and BCIRG-006 predicts the benefit of Herceptin therapy. Cancer Research. 72(24_Supplement). PD02–1. 1 indexed citations
6.
Loibl, Sibylle, Jean Marie Bruey, Gϋnter von Minckwitz, et al.. (2011). Validation of p95 as a predictive marker for trastuzumab-based therapy in primary HER2-positive breast cancer: A translational investigation from the neoadjuvant GeparQuattro study.. Journal of Clinical Oncology. 29(15_suppl). 530–530. 35 indexed citations
7.
Perez, EA, MF Press, RB Jenkins, et al.. (2010). Abstract PD10-02: Round-Robin Review of HER2 Testing in the Context of Adjuvant Therapy for Breast Cancer (NCCTG N9831/BCIRG006/BCIRG005). Cancer Research. 70(24_Supplement). PD10–2. 2 indexed citations
8.
Johnston, Stephen, et al.. (2009). Baseline serum extracellular domain HER2 expression in hormone receptor-positive metastatic breast cancer: correlation with known tissue HER2 status.. Cancer Research. 69(2_Supplement). 3147–3147. 1 indexed citations
9.
Johnston, S., et al.. (2009). Correlation of tumor burden, liver and bone metastasis with serum extracellular domain HER2 expression in front-line metastatic breast cancer.. Cancer Research. 69(2_Supplement). 3146–3146. 1 indexed citations
10.
11.
Koehler, Martin Johannes, Lisa O’Rourke, J. Maltzman, et al.. (2009). Relevance of serum HER2 extracellular domain (sECD) in EGF30008, a study of letrozole ± lapatinib in patients (pts) with hormone-receptor positive (HR+) metastatic breast cancer (MBC). Journal of Clinical Oncology. 27(15_suppl). 1019–1019. 2 indexed citations
12.
Press, MF, RS Finn, Angelo Di Leo, et al.. (2008). Correlation of HER2 gene amplification, HER2 and EGFR expression (protein and mRNA) with lapatinib efficacy in women with metastatic breast cancer. Journal of Clinical Oncology. 26(15_suppl). 1007–1007. 8 indexed citations
13.
Gray, Joe W., Wen‐Lin Kuo, MF Press, et al.. (2008). Identification of a 6 gene molecular predictor of lapatinib related benefit: From breast cancer cell lines to a phase III trial. Journal of Clinical Oncology. 26(15_suppl). 1043–1043. 3 indexed citations
14.
Press, MF, Judy Dering, Henry Gómez, et al.. (2007). 2097 ORAL Biomarker analysis of lapatinib with paclitaxel versus paclitaxel as first-line treatment in 580 patients with metastatic breast cancer. European Journal of Cancer Supplements. 5(4). 212–212. 2 indexed citations
15.
16.
McKean‐Cowdin, Roberta, Laurence N. Kolonel, MF Press, MC Pike, & Brian E. Henderson. (2001). Germ-line HER-2 variant and breast cancer risk by stage of disease.. PubMed. 61(23). 8393–4. 37 indexed citations
17.
Mitchell, M S & MF Press. (1999). The role of immunohistochemistry and fluorescence in situ hybridization for HER2/neu in assessing the prognosis of breast cancer.. PubMed. 26(4 Suppl 12). 108–16. 77 indexed citations
18.
Kieback, D G, MF Press, Elizabeth J. Atkinson, et al.. (1995). Die prognostische Differenzierung von Ovarialkarzinomen durch immunhistochemische Analyse der Östrogenrezeptorexpression. Geburtshilfe und Frauenheilkunde. 55(4). 189–194. 1 indexed citations
19.
Kieback, D G, MF Press, E. Neely Atkinson, et al.. (1993). Improved prediction of survival in advanced adenocarcinoma of the ovary by immunocytochemical analysis and the composition adjusted receptor level of the estrogen receptor.. PubMed. 53(21). 5188–92. 14 indexed citations
20.
Greene, Geoffrey L. & MF Press. (1987). Monoclonal antibodies to estrogen and progesterone receptors immunoassays for er and pgr. Tumor Biology. 8(6). 283.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Richard Finn Breakdown of academic impact, for papers by Karen Yuan Breakdown of academic impact, for papers by Rochelle Strenger Breakdown of academic impact, for papers by Danai Fimereli Breakdown of academic impact, for papers by JMS Bartlett Breakdown of academic impact, for papers by Federica Predolini Breakdown of academic impact, for papers by Małgorzata Foszczyńska‐Kłoda Breakdown of academic impact, for papers by Luca Boscolo Bielo Breakdown of academic impact, for papers by Elisa Minenza Breakdown of academic impact, for papers by Daniela Boggiani
Rankless by CCL
2026